BRIZZI, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 5.152
NA - Nord America 4.916
AS - Asia 2.102
SA - Sud America 406
AF - Africa 37
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.627
Nazione #
US - Stati Uniti d'America 4.839
GB - Regno Unito 1.190
IT - Italia 1.083
RU - Federazione Russa 955
CN - Cina 777
SG - Singapore 654
IE - Irlanda 620
BR - Brasile 341
SE - Svezia 300
DE - Germania 265
UA - Ucraina 233
FR - Francia 211
HK - Hong Kong 178
KR - Corea 147
FI - Finlandia 118
VN - Vietnam 89
IN - India 77
TR - Turchia 45
CA - Canada 35
JP - Giappone 29
PL - Polonia 29
ES - Italia 27
MX - Messico 27
NL - Olanda 27
AR - Argentina 24
BD - Bangladesh 17
AT - Austria 16
BE - Belgio 16
EC - Ecuador 13
AU - Australia 12
PK - Pakistan 11
ZA - Sudafrica 11
CI - Costa d'Avorio 10
ID - Indonesia 10
IQ - Iraq 10
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
PT - Portogallo 8
CL - Cile 7
SA - Arabia Saudita 7
EE - Estonia 6
VE - Venezuela 6
IR - Iran 5
LT - Lituania 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
UZ - Uzbekistan 5
GR - Grecia 4
IL - Israele 4
LV - Lettonia 4
PY - Paraguay 4
SN - Senegal 4
TW - Taiwan 4
AM - Armenia 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GE - Georgia 3
JO - Giordania 3
KE - Kenya 3
LK - Sri Lanka 3
MA - Marocco 3
PE - Perù 3
RS - Serbia 3
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
RO - Romania 2
SR - Suriname 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
TH - Thailandia 1
Totale 12.627
Città #
Southend 1.081
Dallas 722
Dublin 618
Fairfield 498
Singapore 373
Ashburn 316
Siena 309
Moscow 266
Santa Clara 266
Menlo Park 252
Chandler 251
Beijing 249
Woodbridge 231
Wilmington 196
Jacksonville 184
Hong Kong 177
Seattle 164
Houston 159
Cambridge 143
Seoul 141
Hefei 140
Ann Arbor 138
Princeton 108
Milan 99
Los Angeles 80
Florence 79
Nanjing 77
Helsinki 60
Fremont 53
New York 51
Rome 43
Boardman 42
Munich 42
San Mateo 38
The Dalles 35
São Paulo 31
Bengaluru 30
Dearborn 30
Ho Chi Minh City 30
Izmir 25
London 25
San Diego 25
Council Bluffs 23
Shanghai 23
Tokyo 23
Nanchang 21
Buffalo 20
Redondo Beach 20
Düsseldorf 19
Hanoi 19
Shenyang 19
Columbus 18
Frankfurt am Main 18
Naples 17
Turku 17
Chicago 16
Tianjin 15
Brooklyn 14
Brussels 14
Guangzhou 13
Nuremberg 12
San Francisco 12
Vienna 12
Warsaw 12
Bari 11
Hebei 11
Piscataway 11
Abidjan 10
Cardiff 10
Dong Ket 10
Kunming 10
L’Aquila 10
Norwalk 10
Paris 10
Redwood City 10
Rio de Janeiro 10
Bologna 9
Brescia 9
Mogliano 9
Montreal 9
Candiolo 8
Chennai 8
Denver 8
Falkenstein 8
Johannesburg 8
Manchester 8
Palermo 8
Toronto 8
Venezia 8
Washington 8
Zhengzhou 8
Aligarh 7
Amsterdam 7
Anguillara Sabazia 7
Boston 7
Jakarta 7
Lauterbourg 7
Melbourne 7
Mestre 7
Orem 7
Totale 8.564
Nome #
Ligandi TRPV1 453
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 364
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 and CB2 receptor ligands 329
Cytotoxic effects of cannabinoids on human HT-29 colorectal adenocarcinoma cells: different mechanisms of THC, CBD, and CB83 326
Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors 281
Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators 277
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 274
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains 250
Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening 245
Design, synthesis and biological evaluation of light-driven on-off multitarget AChE and MAO-B inhibitors 244
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility 240
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: Involvement of the GABAB and cannabinoid CB1 receptors 237
Synthesis of pyrazolo[1,5-a]pyrimidine ring as a possible bioisosteric replacement of the 5-(1H-pyrrol-1-yl)pyrazole scaffold 232
Synthesis and biological evaluation of New N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands 226
Screen of unfocused libraries identified compounds with direct or synergistic antibacterial activity 226
Dihydro-alkylthio-benzyl-oxopyrimidines as Inhibitors of Reverse Transcriptase: Synthesis and Rationalization of the Biological Data on Both Wild-Type Enzyme and Relevant Clinical Mutants 223
Regioselective functionalization of quinolin-4(1H)-ones via sequential palladium-catalyzed reactions 222
Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol 217
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 215
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 214
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 6. Synthesis and Pharmacological Evaluation of 7-Substituted 4-Quinolone-3-carboxamide Derivatives as High Affinity Ligands for Cannabinoid Receptors 211
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoids Receptors 202
Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides 201
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors 201
3-Amino-alkylated indoles: Unexplored green products acting as anti-inflammatory agents 201
A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of CaV1.2 and KCa1.1 channels 201
Synthesis and antitumor activities of a series of novel quinoxalinhydrazides 200
Active manganese dioxide promoted cyclization of ortho-(1H-pyrrol-1-yl)aryl and heteroaryl carboxylic acids to 5H-pyrrolo[1,2-a][3,1]benzoxazin-5-one derivatives 200
Nuovi Potenti e Selettivi ligandi dei recettori dei cannabinoidi 199
Design, synthesis, and physicochemical and pharmacological profiling of 7‐Hydroxy-5-oxopyrazolo[4,3‐b]pyridine-6-carboxamide derivatives with antiosteoarthritic activity in vivo 198
Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N-alkylacetamides as CB2 receptor ligands 196
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor 195
Design, synthesis and pharmacological evaluation of ester-based quercetin derivatives as selective vascular KCa1.1 channel stimulators 195
Anti-Inflammatory and Antinociceptive Properties of the Quercetin-3-Oleate AV2, a Novel FFAR1 Partial Agonist 192
Synthetic bioactive olivetol-related amides: the influence of the phenolic group in cannabinoid receptor activity 188
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 187
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 186
TRPV1-FAAH-COX: The Couples Game in Pain Treatment 184
Anti-addictive properties of COR659 – Additional pharmacological evidence and comparison with a series of novel analogues 183
Conformational Analysis of the N-Arachinylethanolamide (Anandamide) using Nuclear Magnetic Resonance and Theoretical Calculations 176
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist 174
Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors 174
HIV-Reverse Transcriptase Inhibition: Inclusion of Ligand-Induced Fit by Cross-Docking Studies 171
Thiazolothiazepine Inhibitors of HIV-1 Integrase 170
Identification and Quantification of Trans-Resveratrol in Dietary Supplements by a Rapid and Straightforward RP-HPLC Method 161
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile 159
Pinocembrin and its linolenoyl ester derivative induce wound healing activity in HaCaT cell line potentially involving a GPR120/FFA4 mediated pathway 158
Polycondensed Heterocycles. Part 11: Preparation and Regioselective Reductions of 5-Phenyl-4H-pyrrolo[1,2-a][1]benzazepin-4-one 156
Design, synthesis and in vitro experimental validation of novel TRPV4 antagonists inspired by labdane diterpenes 148
Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii 145
An approach to the stereo-controlled synthesis of polycyclic derivatives of L-4-thiazolidinecarboxilic acid active against HIV-1 integrase 145
Suppressing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on locomotor hyperactivity induced by different drugs of abuse 141
New synthesis of N1- and N2-substituted pyrazolo[4,3-b]pyridine-5-one derivatives as CB2 receptor ligands 128
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 127
Lipoic/Capsaicin-Related Amides: Synthesis and Biological Characterization of New TRPV1 Agonists Endowed with Protective Properties against Oxidative Stress 126
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands 124
Targeting neuropathic pain: pathobiology, current treatment and peptidomimetics as a new therapeutic opportunity 120
Napthoxazepine Inhibitors of HIV-1 Integrase: Synthesis and Biological Evaluation 119
GPR120/FFAR4 pharmacology: focus on agonists in Type 2 diabetes mellitus drug discovery 113
Old strategies and new perspectives in modulating the endocannabinoid system 109
Development of 1-(2-aminophenyl)pyrrole-based amides acting as human topoisomerase I inhibitors 107
Synthesis of some novel 1-aryl-1H-1,2,3-triazole-4-carboxamides and ethyl 1-aryl-5-(1,2,3-triazol-1-yl)-1H-pyrazole-4-carboxylates 106
Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists 99
Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor 99
Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity 93
The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 89
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo 87
Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists/potential negative allosteric modulators 86
Totale 12.825
Categoria #
all - tutte 39.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021953 0 0 0 0 0 134 91 169 125 245 116 73
2021/20221.054 84 121 97 102 64 41 50 55 45 113 96 186
2022/20231.150 81 88 177 136 100 225 45 92 91 29 60 26
2023/20241.133 58 24 92 63 63 236 363 36 17 40 28 113
2024/20252.156 59 98 230 127 247 145 98 134 178 114 207 519
2025/20263.248 390 779 575 586 876 42 0 0 0 0 0 0
Totale 12.825